MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

NCT02707107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Serious Gram-negative Infections

Interventions

DRUG: Intravenous infusions of WCK 5222
DRUG: Placebo

Sponsor

Wockhardt

Collaborators

[object Object]